FMXIN002

· Nasus Pharma

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FMXIN002, covering 2025-07-01 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis [Phase 1, Phase 2]